# Paroxetine

## Seroxat CR 12.5mg

#### 一般可用

| 藥品代碼       | OSER1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:---------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | ■Generalized anxiety disorder ■Major depressive disorder ■Obsessive-compulsive disorder ■Panic disorder ■Posttraumatic stress disorder ■Premenstrual dysphoric disorder ■Social phobia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 用法用量       | Major depressive disorder: controlled-release， 25 mg/day ORALLY in the morning; may increase dosage by 12.5-mg/day increments at intervals of at least 1 week to a MAX dose of 62.5 mg/day Panic disorder: controlled-release， 12.5 mg/day ORALLY in the morning; may increase dosage by 12.5-mg/day increments at intervals of at least 1 week to a MAX dose of 75 mg/day Premenstrual dysphoric disorder: controlled-release， 12.5 mg/day ORALLY in the morning; may increase to 25 mg/day at interval of at least 1 week; may be administered daily throughout the menstrual cycle or limited to daily administration during the luteal phase of the menstrual cycle Social phobia: controlled-release， 12.5 mg/day ORALLY in the morning; may be increased by 12.5-mg/day increments at intervals of at least 1 week to a MAX dose of 37.5 mg/day                                                                                   |
| 肝功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 腎功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 禁忌           | ■coadministration with an MAOI， including linezolid or IV methylene blue， or use of paroxetine hydrochloride within 14 days of discontinuing an MAOI used to treat psychiatric disorders， or use of an MAOI used to treat psychiatric disorders within 14 days of discontinuing paroxetine hydrochloride; increased risk of serotonin syndrome ■concomitant use with pimozide ■concomitant use with thioridazine ■hypersensitivity to paroxetine or any component of the product                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 副作用         | Common ■Cardiovascular: Palpitations (up to 3% )， Vasodilatation (2% to 4% ) ■Dermatologic: Diaphoresis (5% to 14% ) ■Gastrointestinal: Constipation (up to 16% )， Diarrhea (up to 18% )， Loss of appetite (up to 9% )， Nausea (up to 26% )， Xerostomia (9% to 18% ) ■Neurologic: Asthenia (up to 22% )， Dizziness (6% to 14% )， Headache (17% to 27% )， Insomnia (up to 24% )， Somnolence (up to 24%)， Tremor (4% to 11% ) ■Ophthalmic: Blurred vision (up to 5% ) ■Reproductive: Abnormal ejaculation (13% to 28% )， Impotence (2% to 9% )， Orgasm disorder (females; 2% to 9% )， Reduced libido (males: 6% to 15%; females: 0% to 9%) ■Respiratory: Yawning (4% ) Serious ■Dermatologic: Stevens-Johnson syndrome， Toxic epidermal necrolysis ■Hepatic: Acute hepatitis (rare) ■Neurologic: Seizure (0.1% ) ■Psychiatric: Depression， exacerbation， Suicidal thoughts (rare)， Suicide (rare) ■Other: Serotonin syndrome |
| 孕期用藥建議   | Human (and animal) data suggest risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 哺乳期用藥建議 | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

